Eli Lilly has launched a completely new application that will permit self-pay back clients to purchase the weight-loss drug Zepbound for as very little as $399 a month—lower than 50 percent the listing price of other incretin medicines employed for patients with obesity.Mounjaro is actually a twin-action GLP-one/GIP medication identified as tirze